InvestorsHub Logo

YN2

Followers 32
Posts 584
Boards Moderated 0
Alias Born 03/02/2013

YN2

Re: Norton1973 post# 32723

Thursday, 03/20/2014 11:06:37 PM

Thursday, March 20, 2014 11:06:37 PM

Post# of 50668
I agree, this should easily be valued at a .01 with the patents they already hold and future game changing patents.

MCT-485 has demonstrated in in vitro models the ability to kill transformed liver cancer cells while not harming normal, non-transformed liver cells. "MCT-485 addresses the need to directly target liver cancer cells and not normal liver cells"